J Clin Pharmacol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Sign In to gain access to subscriptions and/or personal tools.
The Journal of Clinical Pharmacology and the Journal of New Drugs, 1968; 8:164-171
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Free, S. M.
Right arrow Articles by Guthrie, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Free, S. M.
Right arrow Articles by Guthrie, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

A Methodology Using Subjective Responses to Discriminate Between Pharmaceutical Preparations

Spencer M. Free Ph.D.1 and Marshall Guthrie M.D.1

1 Research and Development Division, Smith Kline & French Laboratories, Philadelphia, Penn.

A double-blind crossover study was conducted to compare placebo, a plain form of dextroamphetamine, and a sustained-release form of dextroamphetamine in 30 volunteers. Measurements included blood pressure, pulse, and an adjective checklist. Data were recorded before drug administration and 3, 5, 7, and 9 hours after administering the single-dose regimens.

Principal component analyses of the adjective checklist developed several factors for further analyses. Three factors reported were named "active,""drowsy," and "stimulation." The first two factors were found in the predrug, placebo, and active drug data. The "stimulation" factor was found only in the dextroamphetamine data.

All criteria show a statistically significant difference between average responses following the placebo and averages for the active regimens.

Systolic blood pressure and average scores for the three factors all show statistically significant drug form-by-time interactions. Tables of averages show an early maximum response for the plain form compared with a delayed and lower maximum response for the sustained-release form.

Scores for the "stimulation" factor also show a statistically significant difference between the overall results of the two active regimens. Consistently higher averages in factor scores are reported for the plain form.

Several statistically desirable features of the methodology and experimental design are discussed.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Arch Gen PsychiatryHome page
L. E. Hollister and H. K. Gillespie
Marihuana, Ethanol, and Dextroamphetamine: Mood and Mental Function Alterations
Arch Gen Psychiatry, September 1, 1970; 23(3): 199 - 203.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1968 by the American College of Clinical Pharmacology